Ex Vivo Engineering of the Tumor Microenvironment (Cancer Drug Discovery and Development) - Image 1

£106.16

Humana Ex Vivo Engineering of the Tumor Microenvironment (Cancer Drug Discovery and Development)

Name: Ex Vivo Engineering of the Tumor Microenvironment (Cancer Drug Discovery and Development)
Brand: Humana
Price: 107.82 GBP
Availability: InStock

Oncology

New to our records — first sighting 18 days ago. We'll learn its rhythm.

18 days of data · current price £106

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 18 days • 18 data points

Historical

Generating forecast...

Price Distribution

Price distribution over 18 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £108 (13 days, 72.2%)

Price range: £106 - £108

Price levels: 3 different prices over 18 days

Description

Product Description This volume will outline how to recreate the tumor microenvironment, to culture primary tumors without the need for developmental priming factors, and to deliver targeted therapeutics in a manner that recapitulates pharmacokinetics in vivo. Much of what may be learned from this volume will aid in understanding many aspects of the enhanced study of tumor cell biology in a physiologic context, open new avenues for drug screening and biomarker development, and accelerate the preclinical evaluation of novel personalized medicine strategies for patients in real time. From the Back Cover This volume will outline how to recreate the tumor microenvironment, to culture primary tumors without the need for developmental priming factors, and to deliver targeted therapeutics in a manner that recapitulates pharmacokinetics in vivo. Much of what may be learned from this volume will aid in understanding many aspects of the enhanced study of tumor cell biology in a physiologic context, open new avenues for drug screening and biomarker development, and accelerate the preclinical evaluation of novel personalized medicine strategies for patients in real time. About the Author Amir R. Aref, PhD, is Instructor, Dana-Farber Cancer Institute, Harvard Medical School.

Product Specifications

Brand: Humana
Format: paperback
ASIN: 3319832824
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 30 April 2018
Listed Since: 30 April 2018

Barcode

No barcode data available

Humana Ex Vivo Engineering of the Tumor Microenvironment (Cancer Drug Discovery and Development)

New to our records — first sighting 18 days ago. We'll learn its rhythm.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

In Vivo Imaging of Cancer Therapy (Cancer Drug Discovery and Development)

Molecular Targeting in Oncology (Cancer Drug Discovery and Development)

Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)

Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics (Cancer Drug Discovery and Development)

Systems Biology of Tumor Microenvironment: Quantitative Modeling and Simulations: 936 (Advances in Experimental Medicine and Biology, 936)

Chemosensitivity: Volume II: In Vivo Models, Imaging, and Molecular Regulators: 111 (Methods in Molecular Medicine, 111)

Bacterial Therapy of Cancer: Methods and Protocols: 1409 (Methods in Molecular Biology, 1409)

MicroRNA and Cancer: Methods and Protocols: 1699 (Methods in Molecular Biology, 1699)

Integrin Targeting Systems for Tumor Diagnosis and Therapy (Methods in Pharmacology and Toxicology)

Experimental and Applied Immunotherapy

Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)

Nuclear Signaling Pathways and Targeting Transcription in Cancer (Cancer Drug Discovery and Development)

Cancer Stem Cells: Methods and Protocols: 1692 (Methods in Molecular Biology, 1692)

Natural Products and Cancer Drug Discovery (Cancer Drug Discovery and Development)

Tumor Cell Metabolism: Pathways, Regulation and Biology

Hypoxia-induced Tumor Heterogeneity and Immune Evasion: Clinical Interventions (Novel approaches to overcome cancer resistance to conventional therapies)

Non-Hodgkin Lymphoma: Prognostic Factors and Targets (Cancer Drug Discovery and Development)

Gene Therapy of Solid Cancers: Methods and Protocols: 1317 (Methods in Molecular Biology, 1317)

Tumor Dormancy and Recurrence (Cancer Drug Discovery and Development)

Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)

Pioneering Precision in Cancer Treatment through 3D Bioprinting

Morphofunctional Aspects of Tumor Microcirculation

Tumor Organoids (Cancer Drug Discovery and Development)

Inflammation and Cancer: Methods and Protocols: Volume 2, Molecular Analysis and Pathways: 512 (Methods in Molecular Biology, 512)